TRCT
MIRA icon

Tower Research Capital (TRC)’s MIRA Pharmaceuticals MIRA Stock Holding History

Tower Research Capital (TRC)’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.32K Buy
4,976
+3,146
+172% +$3.94K ﹤0.01% 4127
2025
Q4 		$2.76K Buy
1,830
+33
+2% +$48 ﹤0.01% 4477
2025
Q3 		$2.44K Buy
+1,797
New +$2.61K ﹤0.01% 4630
2025
Q1 		– Sell
-6,901
Closed -$7.87K – 5560
2024
Q4 		$7.87K Buy
+6,901
New +$9.01K ﹤0.01% 4034

Other funds holding MIRA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CSI
Cross Staff Investments Pittsford, New York $197M AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FAB
First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Tower Research Capital (TRC)'s MIRA Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its MIRA Pharmaceuticals (MIRA) stake by 172% in Q1 2026, buying an estimated $3.94K and bringing the position to 4,976 shares worth $5.32K. The position accounts for ﹤0.01% of the portfolio, ranked #4127.

Tower Research Capital (TRC) first reported a position in MIRA in Q4 2024 and has held it in 4 quarters since. The position peaked at $7.87K in Q4 2024. 26 funds tracked by Wall St. Rank hold MIRA as of Q1 2026.

  • Tower Research Capital (TRC) held 4,976 shares of MIRA Pharmaceuticals worth $5.32K as of Q1 2026.
  • Tower Research Capital (TRC) bought 3,146 MIRA Pharmaceuticals shares in Q1 2026, an estimated $3.94K.
  • MIRA Pharmaceuticals made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4127 holding.
  • Tower Research Capital (TRC) first reported a position in MIRA Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • Tower Research Capital (TRC)'s MIRA Pharmaceuticals position peaked at $7.87K in Q4 2024.
  • 26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.